KVISTGÅRD, Denmark, October 7 /PRNewswire/ --

- 125 Patient, Prospective Randomized Placebo-Controlled Phase II Study Shows Statistically Significant Improved Overall Survival

KVISTGÅRD, Denmark, October 7 /PRNewswire/ --

Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US.

MANCHESTER, England, October 7 /PRNewswire/ -- Hospital super bugs may be the biggest challenge facing the NHS but a revolutionary technology - Byotrol - developed by a pioneering British company has helped create a hospital in the United States that is free of hospital acquired MRSA, VRE and C.difficile.

Since the Monroe Hospital opened in Bloomington Indiana, in October 2006 there has never been a recorded case of hospital acquired infection (HCAI).

This breakthrough technology offers a real solution to the UK hospital super bug crisis according to one of the country's foremost experts in hospital acquired infection.

WASHINGTON, October 7 /PRNewswire/ --

CeloNova BioSciences, Inc. today announced that it will showcase the technology behind the CATANIA(TM) Coronary Stent System featuring a NanoThin Polyzene(R)-F surface treatment during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium sponsored by the Cardiovascular Research Foundation October 12-17. The CATANIA(TM) Coronary Stent System carries a CE Mark and is currently available for sale outside the United States.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-a) (Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-b)

VENLO, Netherlands, October 6 /PRNewswire/ --

- QIAGEN's HPV testing technologies are a successful commercialization of the Nobel Prize in Medicine winner's research

NEW YORK, October 6 /PRNewswire/ --

- Commitment Made as Part of Clinton Global Initiative

The American University in Dubai (AUD) announced at the Clinton Global Initiative (CGI) Annual Meeting that it has made a commitment to offer US$26million in scholarship funds to outstanding students in financial need all over the Middle East. These scholarships will help students attend The Mohammed Bin Rashid School for Communication (MBRSC).

(Photo: http://www.newscom.com/cgi-bin/prnh/20081006/CLM092-a ) (Logo: http://www.newscom.com/cgi-bin/prnh/20081006/CLM092LOGO-b )

BILLERICA, Massachusetts, October 6 /PRNewswire/ --

- Novel technology opens the door to the understanding of and possible treatments for obesity, diabetes, ageing and cancer

Seahorse Bioscience today announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells in a 96 well microplate. For the past 75 years tools for measuring cellular bioenergetics have been relatively unchanged since Warburg designed the Warburg Apparatus in 1932 and Leland Clark invented the Clark oxygen electrode in 1959.